Ocular Therapeutix -2.5% as holders file to sell 9.57M shares

Apr. 01, 2019 5:18 PM ETOcular Therapeutix, Inc. (OCUL)OCULBy: Jason Aycock, SA News Editor5 Comments
  • Ocular Therapeutix (NASDAQ:OCUL) is 2.5% lower postmarket after shareholders filed to offer 9.57M shares.
  • That filing proposes a maximum offering price of $3.94 each; shares closed today at $4.07.
  • Of the 9.57M shares covered in the filing, 5.77M are issuable on the conversion of a senior subordinated convertible note between the company and an affiliate of Summer Road LLC, and 3.8M shares held by Summer Road affiliates.
  • The selling stockholders are Cap 1 LLC (which has an 18.4% stake, and would exit its position) and East River Partners (with a 1.5% stake, and also would exit its position).
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.